{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:52:45Z","timestamp":1780095165977,"version":"3.54.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.revmed.2021.02.007","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T16:28:44Z","timestamp":1614961724000},"page":"320-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Syndrome POEMS\u00a0: diagnostic, prise en charge et traitements"],"prefix":"10.1016","volume":"42","author":[{"given":"A.","family":"Talbot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jaccard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Arnulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2021.02.007_bib0320","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1182\/blood-2018-04-839480","article-title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","volume":"132","author":"Fermand","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2021.02.007_bib0325","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00005792-198007000-00006","article-title":"Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature","volume":"59","author":"Bardwick","year":"1980","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2021.02.007_bib0330","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.34.6.712","article-title":"The Crow-Fukase syndrome: a study of 102\u00a0cases in Japan","volume":"34","author":"Nakanishi","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.02.007_bib0335","first-page":"543","article-title":"Plasma cell dyscrasia with polyneuropathy and endocrine disorder: clinical and laboratory features of 109\u00a0reported cases","volume":"13","author":"Takatsuki","year":"1983","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0340","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0002-9343(94)90350-6","article-title":"POEMS syndrome: a study of 25\u00a0cases and a review of the literature. French Study Group on POEMS Syndrome","volume":"97","author":"Soubrier","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2021.02.007_bib0345","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ajh.24802","article-title":"POEMS syndrome: 2017\u00a0Update on diagnosis, risk stratification, and management","volume":"92","author":"Dispenzieri","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0350","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0140-6736(96)91261-1","article-title":"Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome","volume":"347","author":"Watanabe","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2021.02.007_bib0355","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2169\/internalmedicine.39.1101","article-title":"VEGF is causative for pulmonary hypertension in a patient with Crow-Fukase (POEMS) syndrome","volume":"39","author":"Niimi","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.revmed.2021.02.007_bib0360","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/brain\/awh519","article-title":"Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis","volume":"128","author":"Scarlato","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.revmed.2021.02.007_bib0365","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0953-6205(01)00199-6","article-title":"Ratio of serum vascular endothelial growth factor to platelet count correlates with disease activity in a patient with POEMS syndrome","volume":"13","author":"Koga","year":"2002","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.revmed.2021.02.007_bib0370","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2169\/internalmedicine.46.6246","article-title":"Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome","volume":"46","author":"Kanai","year":"2007","journal-title":"Intern Med"},{"key":"10.1016\/j.revmed.2021.02.007_bib0375","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1182\/blood.2019004197","article-title":"Immunoglobulin variable domain high-throughput sequencing reveals specific novel mutational patterns in POEMS syndrome","volume":"135","author":"Bender","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2021.02.007_bib0380","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ajh.21285","article-title":"A novel report of cIg-FISH and cytogenetics in POEMS syndrome","volume":"83","author":"Bryce","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0385","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1038\/s41375-018-0348-x","article-title":"Genetic and transcriptional landscape of plasma cells in POEMS syndrome","volume":"33","author":"Nagao","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2021.02.007_bib0390","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejrad.2009.06.004","article-title":"18F-FDG PET\/CT in the evaluation of POEMS syndrome","volume":"76","author":"Albert\u00ed","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0395","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00330-014-3428-y","article-title":"Computed tomography assessment of bone lesions in patients with POEMS syndrome","volume":"25","author":"Glazebrook","year":"2015","journal-title":"Eur Radiol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0400","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.2967\/jnumed.115.160507","article-title":"Characterizing POEMS. Syndrome with 18F-FDG PET\/CT","volume":"56","author":"Pan","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.revmed.2021.02.007_bib0405","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/mus.24768","article-title":"Thrombocytosis distinguishes POEMS syndrome from chronic inflammatory demyelinating polyneuropathy","volume":"52","author":"Naddaf","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.revmed.2021.02.007_bib0410","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood-2011-06-362392","article-title":"The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome","volume":"118","author":"D'Souza","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2021.02.007_bib0415","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/mus.10182","article-title":"Patterns of nerve conduction abnormalities in POEMS syndrome","volume":"26","author":"Sung","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.revmed.2021.02.007_bib0420","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40478-016-0389-1","article-title":"Nerve pathologic features differentiate POEMS syndrome from CIDP","volume":"4","author":"Piccione","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.revmed.2021.02.007_bib0425","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1529-8027.2003.03019.x","article-title":"Crow-Fukase (POEMS) syndrome: a study of peripheral nerve biopsy in five new cases","volume":"8","author":"Vital","year":"2003","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.revmed.2021.02.007_bib0430","first-page":"84","article-title":"Increased vascular endothelial growth factor (VEGF) is causative in Crow-Fukase syndrome","volume":"39","author":"Arimura","year":"1999","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.revmed.2021.02.007_bib0435","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ophtha.2010.08.013","article-title":"Ocular findings in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome","volume":"118","author":"Kaushik","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2021.02.007_bib0440","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1346-8138.1988.tb01201.x","article-title":"Cutaneous angioma in Crow-Fukase syndrome: the nature of globules within the endothelial cells","volume":"15","author":"Jitsukawa","year":"1988","journal-title":"J Dermatol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0445","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00000478-199011000-00005","article-title":"Glomeruloid hemangioma. A distinctive cutaneous lesion of multicentric Castleman's disease associated with POEMS syndrome","volume":"14","author":"Chan","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0450","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1378\/chest.07-1800","article-title":"Pulmonary manifestations in patients with POEMS syndrome: a retrospective review of 137\u00a0patients","volume":"133","author":"Allam","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.revmed.2021.02.007_bib0455","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00005792-199607000-00005","article-title":"Acute arterial obliteration: a new feature of the POEMS syndrome\u00a0?","volume":"75","author":"Lesprit","year":"1996","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2021.02.007_bib0460","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/(SICI)1097-4598(199704)20:4<486::AID-MUS12>3.0.CO;2-X","article-title":"Coagulation and vascular abnormalities in Crow-Fukase syndrome","volume":"20","author":"Saida","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.revmed.2021.02.007_bib0465","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00415-013-7143-4","article-title":"Papilloedema is an independent prognostic factor for POEMS syndrome","volume":"261","author":"Cui","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0470","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1210\/jc.2018-01516","article-title":"Prevalence and course of endocrinopathy in POEMS syndrome","volume":"104","author":"Caimari","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2021.02.007_bib0475","first-page":"275","article-title":"Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome","volume":"31","author":"Ye","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.revmed.2021.02.007_bib0480","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/1097-0142(19930201)71:3<874::AID-CNCR2820710335>3.0.CO;2-#","article-title":"Castleman disease in POEMS syndrome with elevated interleukin-6","volume":"71","author":"Emile","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2021.02.007_bib0485","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1600-0404.1989.tb03916.x","article-title":"syndrome among Chinese: association with Castleman's disease and some immunological abnormalities","volume":"80","author":"Thajeb","year":"1989","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.revmed.2021.02.007_bib0490","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7326\/0003-4819-114-6-520","article-title":"Castleman disease-POEMS syndrome overlap","volume":"114","author":"Gherardi","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2021.02.007_bib0495","first-page":"293","article-title":"Castleman disease","volume":"142","author":"Dispenzieri","year":"2008","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.revmed.2021.02.007_bib0500","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2021.02.007_bib0505","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/ajh.24356","article-title":"Long-term outcome of patients with POEMS syndrome: an update of the Mayo Clinic experience","volume":"91","author":"Kourelis","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0510","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/leu.2016.168","article-title":"Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome","volume":"31","author":"Wang","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2021.02.007_bib0515","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ajh.25495","article-title":"Syndrome: POEMS, 2019\u00a0Update on diagnosis, risk-stratification, and management","volume":"94","author":"Dispenzieri","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0520","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13014-014-0265-8","article-title":"The role of radiotherapy in the management of POEMS syndrome","volume":"9","author":"Suh","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0525","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1182\/blood-2004-05-2046","article-title":"Peripheral blood stem cell transplantation in 16\u00a0patients with POEMS syndrome, and a review of the literature","volume":"104","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2021.02.007_bib0530","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1182\/blood-2010-12-328112","article-title":"Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome","volume":"117","author":"Li","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2021.02.007_bib0535","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1182\/blood.V99.8.3057","article-title":"High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome","volume":"99","author":"Jaccard","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2021.02.007_bib0540","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1212\/01.wnl.0000323811.42080.a4","article-title":"Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome","volume":"71","author":"Kuwabara","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.02.007_bib0545","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1600-0609.2008.01037.x","article-title":"Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome","volume":"80","author":"Dispenzieri","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0550","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3324\/haematol.11315","article-title":"Treatment of POEMS syndrome with bevacizumab","volume":"92","author":"Samaras","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2021.02.007_bib0555","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1182\/blood-2005-12-5045","article-title":"Bevacizumab therapy for POEMS syndrome","volume":"107","author":"Straume","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2021.02.007_bib0560","first-page":"366","article-title":"Intravenous immunoglobulin therapy in POEMS syndrome: a case report","volume":"58","author":"Chang","year":"1996","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"10.1016\/j.revmed.2021.02.007_bib0565","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41375-019-0391-2","article-title":"What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?","volume":"33","author":"Zhao","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.revmed.2021.02.007_bib0570","unstructured":"POEMS Syndrome: 2019\u00a0Update on diagnosis, risk-tratification, and management - Dispenzieri - 2019 - American Journal of Hematology -."},{"key":"10.1016\/j.revmed.2021.02.007_bib0575","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/jnnp.2008.150177","article-title":"Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome","volume":"79","author":"Kuwabara","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.revmed.2021.02.007_bib0580","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ajh.25100","article-title":"A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome","volume":"93","author":"Li","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0585","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/bjh.14966","article-title":"Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial","volume":"179","author":"Nozza","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0590","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ajh.23374","article-title":"Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20\u00a0patients","volume":"88","author":"Royer","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0595","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.clml.2019.09.062","article-title":"A Prospective Phase II Trial of Lenalidomide and Dexamethasone in POEMS Syndrome. Clinical Lymphoma","volume":"19","author":"Jaccard","year":"2019","journal-title":"Myeloma and Leukemia"},{"key":"10.1016\/j.revmed.2021.02.007_bib0600","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/WNL.0b013e3181bd136b","article-title":"Cerebral infarction in POEMS syndrome: incidence, risk factors, and imaging characteristics","volume":"73","author":"Dupont","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2021.02.007_bib0605","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1474-4422(16)30157-0","article-title":"Japanese POEMS Syndrome for Thalidomide (J-POST) Trial Study Group. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"15","author":"Misawa","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0610","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-0609.2009.01341.x","article-title":"a new therapeutic option for POEMS syndrome","volume":"84","author":"Kaygusuz","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0615","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1600-0609.2009.01330.x","article-title":"Successful bortezomib-based treatment in POEMS syndrome","volume":"83","author":"Tang","year":"2009","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.revmed.2021.02.007_bib0620","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1200\/JCO.2019.37.15_suppl.8019","article-title":"Ixazomib, lenalidomide, and dexamethasone for patients with POEMS syndrome","volume":"37","author":"Dispenzieri","year":"2019","journal-title":"JCO"},{"key":"10.1016\/j.revmed.2021.02.007_bib0625","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.mayocp.2018.02.001","article-title":"Daratumumab for POEMS Syndrome","volume":"93","author":"Khan","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.revmed.2021.02.007_bib0315","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13045-018-0672-7","article-title":"Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myeloma","volume":"11","author":"Xu","year":"2018","journal-title":"J Hematol Oncol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321000321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866321000321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:43:29Z","timestamp":1759337009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866321000321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0248866321000321"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2021.02.007","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndrome POEMS\u00a0: diagnostic, prise en charge et traitements","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2021.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}